Harrison D E, Astle C M
Jackson Laboratory, Bar Harbor, ME 04609-0800, USA.
Blood. 1997 Jul 1;90(1):174-81.
Blood from late fetal and newborn mice is similar to umbilical cord blood obtained at birth in human beings, an important source of stem cells for clinical transplantation. The mouse model is useful because long-term functions can be readily assayed in vivo. To evaluate the functions of hematopoietic precursors in the blood and other tissues of late fetal and newborn mice, short- and long-term multilineage repopulating abilities were measured in vivo by competitive repopulation. Manipulations that might affect cell function, such as enrichment, tissue culture, or retroviral marking, were avoided. Hematopoietic stem cell functions of late fetal or newborn blood, liver, and spleen, were assayed as myeloid and lymphoid repopulating abilities relative to standard adult marrow cells. Donor cells from these tissues as well as adult control donor marrow cells were all of the same genotype. Cells from each donor tissue were mixed with portions from a pool of standard adult "competitor" marrow distinguished from the donors by genetic differences in hemoglobin and glucosephosphate isomerase. After 21 to 413 days, percentages of donor type myeloid and lymphoid cells in recipient blood were measured to assay the functional abilities of donor precursors relative to the standard. These relative measures are expressed as repopulating units, where each unit is equivalent to the repopulating ability found in 100,000 standard adult marrow cells. Thus, measures of repopulating units do not compare single cells but overall repopulating abilities of donor cell populations. Relative functional abilities in 1 million nucleated cells from late fetal or newborn blood were several times less than those found in adult marrow, but far more than in normal adult blood, and appeared to include long-term functional primitive hematopoietic stem cells (PHSC) similar to those in marrow. To estimate functional abilities of individual PHSC, variances among large groups of identical recipients were analyzed using both the binomial model and competitive dilution, a new model based on the Poisson distribution. The data best fit the hypothesis that individual PHSC from adult marrow, late fetal blood, or newborn blood each produce similar fractions of the total lymphoid and erythroid cells found in the recipient for many months.
来自晚期胎儿和新生小鼠的血液类似于人类出生时获取的脐带血,而脐带血是临床移植中干细胞的重要来源。小鼠模型很有用,因为可以在体内轻松检测长期功能。为了评估晚期胎儿和新生小鼠血液及其他组织中造血前体细胞的功能,通过竞争性移植在体内测量了短期和长期多谱系重建能力。避免了可能影响细胞功能的操作,如富集、组织培养或逆转录病毒标记。检测了晚期胎儿或新生血液、肝脏和脾脏的造血干细胞功能,以相对于标准成年骨髓细胞的髓系和淋巴系重建能力来衡量。来自这些组织的供体细胞以及成年对照供体骨髓细胞均具有相同的基因型。将每个供体组织的细胞与来自标准成年“竞争”骨髓库的部分细胞混合,通过血红蛋白和葡萄糖磷酸异构酶的基因差异将其与供体区分开来。21至413天后,测量受体血液中供体型髓系和淋巴系细胞的百分比,以检测供体前体细胞相对于标准的功能能力。这些相对测量值以重建单位表示,其中每个单位相当于在100,000个标准成年骨髓细胞中发现的重建能力。因此,重建单位的测量不是比较单个细胞,而是供体细胞群体的整体重建能力。晚期胎儿或新生血液中100万个有核细胞的相对功能能力比成年骨髓中的低几倍,但远高于正常成年血液中的能力,并且似乎包括与骨髓中相似的长期功能性原始造血干细胞(PHSC)。为了估计单个PHSC的功能能力,使用二项式模型和竞争性稀释(一种基于泊松分布的新模型)分析了大量相同受体群体之间的差异。数据最符合这样的假设,即来自成年骨髓、晚期胎儿血液或新生血液的单个PHSC在许多个月内各自产生受体中发现的总淋巴系和红系细胞的相似比例。